Trial Details

COMPLETED
Basic Information
Clinical ID c1286
Identifier NCT03368118
Trial Title Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: ABX464
Participant Information
Sponsor Abivax S.A.
City Leuven
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2018-01-20
Primary Completion Date 2019-03-08
Completion Date 2022-08-15